Avita Medical (RCEL)
(Delayed Data from NSDQ)
$5.28 USD
-0.07 (-1.31%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $5.27 -0.01 (-0.19%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Avita Medical Inc. has a market cap of $141.43M, which represents its share price of $5.35 multiplied by its outstanding shares number of 26.43M. As a small-cap company, RCEL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RCEL 5.28 -0.07(-1.31%)
Will RCEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCEL
Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect?
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know
RCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for RCEL
AVITA Medical to Announce Second Quarter 2025 Financial Results | RCEL Stock News
Notable Tuesday Option Activity: RCEL, RYAM, SOFI
Top 3 Health Care Stocks You'll Regret Missing This Quarter
AVITA Medical (RCEL) Receives Continued 'Buy' Rating from D. Boral Capital | RCEL Stock News
TD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)